References
- P. Loiseau, Rational use of valproate: Indications and drug regimen in epilepsy, Epilepsy 25 (1984) 65-72; DOI: 10.1111/j.1528-1157.1984.tb05641.x.
- O. Dulac, D. Steru, E. Rey and M. Arthius, Sodium valproate monotherapy in childhood epilepsy, Brain Dev. 8 (1986) 47-52.
- D. C. Lagacea, W. T. O'Brienb, N. Gurvichb, M. W. Nachtigala and P. S. Klein, Valproic acid: How it works. Or not, Clin. Neurosci. Res. 4 (2004) 215-225; DOI: 10.1016/j.cnr.2004.09.013.
- P. Wal, B. Kumar, A. Bhandari, A. K. Rai and A. Wal, Bioanalytical method development - Determination of drugs in biological fluids, J. Pharm. Sci. Tech. 2 (2010) 333-347.
- S. I. Johannessen, Therapeutic Drug Monitoring of Antiepileptic Drugs, in Drug Monitoring and Clinical Chemistry (Ed. G. Hempel) in Elsevier, Amsterdan 2004, in (Ed. R. M. Smith) Handbook of Analytical Separation. Vol. 5, pp. 221-253; DOI: 10.1016/S1567-7192(04)80010-X.
- P. N. Patsalos, D. J. Berry, B. F. D. Bourgeois, J. C. Cloyd, T. A. Glauser, S. I. Johannessen, I. E. Leppik, T. Tomson and E. P. Patsalos, Antiepileptic drugs - best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on the therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies, Epilepsia (2008) 1-38; DOI: 10.1111/j.1528-1167.2008.01561.x.
- S. J. Soldin, Free drug measurement, Arch. Pathol. Lab. Med. 123 (1999) 822-823.
- H. Liu and M. R. Delgado, Therapeutic drug concentration monitoring using saliva samples, Clin. Pharmacokin. 36 (1999) 453-470; DOI: 10.2165/00003088-199936060-00006.
- H. S. Chung, T. L. Seung and L. Soo-Youn, Evaluation of Viva-E drug testing system, Korean J. Lab. Med. 27 (2007) 330-337; DOI: 10.3343/kjlm.2007.27.5.330.
- R. L. Dills and D. D. Shen, Methods to reduce background interferences in electron-capture gas chromathographic analysis of valproic acid and its unsaturated metabolites after derivatization with pentafluorobenzyl bromide, J. Chromatogr. B Biomed. Appl. 690 (1997) 139-152; DOI: 10.1016/S0378-4347(96)00405-7.
- S. Rompotis, M. Parissi-Poulou, E. Gikas, M. Kazanis, A. Vavayannis and I. Panderi, Determination of valproic acid in human plasma by HPLC with fluorescence detection, J. Liq. Chromatogr. 25 (2002) 2833-2847; DOI: 10.1081/JLC-120014953.
- H. Amini, M. Javan and A. Ahmadiani, Development and validation of a sensitive assay of valproic acid in human plasma by high-performance liquid chromatography without prior derivatization, J. Chromatogr. B 830 (2006) 368-371; DOI: 10.1016/j.jchromb.2005.11.028.
- D. S. Jain, G. Subbaiah, M. Sanyal and P. Shrivastav, A high through and selective method for the estimation of valproic acid an antiepileptic drug in human plasma by tandem LC-MS/MS, Talanta 72 (2007) 80-88.
- Guideline on validation of bioanalytical methods, European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP), London 2009; http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/12/WC500018062.pdf
- M. Krogh, K. Johansen, F. Tonnesen and K. E. Rasmussen, Solid-phase microextraction for the determination of the free concentration of valproic acid in human plasma by capillary gas chromatography, J. Chromatogr. B 673 (1995) 299-305; DOI: 10.1016/03784347(95)00273-8.